🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

AMN Healthcare Services, Inc. AMN R2K

Healthcare · Medical Care Facilities · United States
https://www.amnhealthcare.com
Company Profile ↓
$32.35
+56.51% 1Y
Mkt Cap$1.25B
P/E-39.45
P/B1.76
52W High$35.77
52W Low$15.10
Book Value$18.44
EPS (TTM)$-0.82

Company Overview

AMN Healthcare Services, Inc. provides technology-enabled healthcare workforce solutions and staffing services to acute and sub-acute care hospitals, and other healthcare facilities in the United States. It operates through three segments: Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions. It offers travel nurse staffing, labor disruption staffing, local staffing, international nurse permanent placement, allied staffing, crisis nurse staffing for critical staffing and rapid response nursing, and allied health professionals, such as skilled nursing facilities, rehabilitation clinics, schools, and pharmacies, as well as physician and advanced practice staffing, and revenue cycle solutions. The company also provides allied health professionals, such as physical therapists, respiratory therapists, occupational therapists, medical and radiology technologists, lab technicians, speech pathologists, rehabilitation assistants, and pharmacists; and solutions for schools, including teletherapy platform, Televate, and qualified school speech-language pathologists, psychologists, nurses, social workers, and other care providers. In addition, it offers locum tenens staffing, healthcare interim leadership staffing, executive search, and physician permanent placement solutions. Additionally, the company provides language services, vendor management systems, workforce optimization, and outsourced solutions. The company offers its services under the brands, including AMN Healthcare, Nursefinders, O'Grady Peyton International, Connetics, Medical Search International, DRW Healthcare Staffing, and B.E. Smith. AMN Healthcare Services, Inc. was founded in 1985 and is based in Dallas, Texas.

Why Investors Should Care

Positive Free Cash Flow

Generates positive free cash flow, funding growth and shareholder returns internally.

Recent Developments

  • Dec 2025 Revenue of $2.73B (-8.5% YoY); net profit $-95.70M.
  • Trailing 12 Months Year-on-year growth — revenue +99.9%.
  • 5-Year Trend Long-term compounding — revenue CAGR -19.5%, profit CAGR -40.5%.

Growth & Price Performance

Compounded Sales Growth

5 Years:-19.55%
1 Year:99.90%

Compounded Profit Growth

5 Years:-40.52%
1 Year:-

Stock Price Performance

1 Year:+56.51%
6 Months:+105.40%
3 Months:+72.26%
1 Month:+5.03%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bullish
52-Week Range 83% of range
$15.10 $35.77
Trend Signals
  • Price vs 50-DMAAbove
  • Price vs 200-DMAAbove
  • RSI (14)52.77 · Neutral
Price Performance
1M+5.03%
3M+72.26%
6M+105.40%
1Y+56.51%

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Generates positive free cash flow.
  • In a confirmed uptrend (50-DMA above 200-DMA).

CONS

  • Revenue declined at -19.5% CAGR over 5 years.
  • Earnings shrank at -40.5% CAGR over 5 years.

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
-39.45
Industry PE
25.88
Forward P/E
29.79
PEG Ratio
1.22
Book Value
$18.44
Price to Book
1.76
P/S
0.37
EV/EBITDA
5.29
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
-19.55%
Profit 5Y
-40.52%
Revenue (YoY)
99.90%
Earnings (YoY)
-

Profitability & Returns

ROCE
-3.66%
ROE
-4.54%
ROA
3.45%
Profit Margin
-0.95%
Op Margin
8.50%
Gross Margin
27.63%
EPS (Latest Qtr)
$1.59
EPS (TTM)
$-0.82

Balance Sheet & Liquidity

Debt/Equity
1.09
Quick Ratio
0.96
Current Ratio
1.09
Debt
$776.92M
Total Assets
$2.60B
Current Assets
$1.14B
Working Capital
$-32.24M

Ownership

Promoter Holding
0.97%
Chg in Prom Hold
-0.02%
FII / Inst Holding
115.66%
Chg in FII Hold
0.12%

Financial Snapshot

Enterprise Value
$1.25B
Total Revenue (TTM)
$3.42B
EBITDA
$290.23M
Free Cash Flow
$671.52M
Operating Cash Flow
$739.24M
Shares Outstanding
38.79M
Gross Margin
27.63%
Payout Ratio
0.00%

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP $P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 AMN AMN Healthcare Services, Inc. R2K 32.35 -39.45 $1.25B 0.00% -3.66% -4.54% -19.55% -40.52%
2 LLY Eli Lilly and Company SPX 1,156.63 41.13 $1.03T 0.60% - 107.46% 7.20% 11.41%
3 JNJ Johnson & Johnson SPX 247.02 28.66 $594.63B 2.23% 14.88% 26.42% 2.43% 4.76%
4 ABBV AbbVie Inc. SPX 244.11 119.08 $431.29B 3.04% 10.47% -129.24% 1.75% -29.06%
5 UNH UnitedHealth Group Incorporated SPX 418.52 31.54 $380.08B 2.18% 9.74% 12.18% 10.40% 5.43%
6 MRK Merck & Co., Inc. SPX 123.61 34.82 $305.29B 2.82% - 18.94% 5.64% 10.01%
7 AZN AstraZeneca PLC NDX 168.37 26.10 $261.12B 1.87% 15.97% 23.48% 9.82% 45.96%
8 TMO Thermo Fisher Scientific Inc. SPX 535.29 29.40 $198.93B 0.35% 8.14% 13.52% 8.81% 12.95%
9 AMGN Amgen Inc. NDXSPX 358.32 24.92 $193.39B 2.80% 18.02% 101.32% 11.77% 5.58%
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Jun 2015Sep 2015Dec 2015Mar 2016Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020Sep 2020Dec 2020Mar 2021Jun 2021Sep 2021Mar 2022Jun 2022Sep 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue -------495.17M489.80M494.41M509.08M522.49M558.11M526.84M528.63M532.44M535.18M567.60M586.89M602.46M608.35M551.63M631.27M885.95M857.45M877.80M1.55B1.43B1.14B1.13B991.30M853.46M820.88M740.68M-689.53M658.17M634.50M748.23M1.38B
Cost of Revenue -----------------------------------491.41M461.78M450.08M553.10M1.01B
Gross Profit 110.12M126.01M131.80M151.90M154.75M154.47M158.61M161.78M161.01M159.54M162.09M167.82M180.96M175.15M172.46M176.76M179.54M190.03M197.13M202.07M197.54M184.63M207.54M288.87M280.54M305.87M496.17M460.24M385.03M368.85M330.28M289.51M257.51M229.83M-198.12M196.40M184.41M195.13M368.84M
Operating Expenses -----------------------------------185.61M192.34M175.97M186.97M251.66M
Operating Income 30.16M37.61M-47.31M47.88M46.68M-52.03M56.38M50.83M-55.20M54.81M42.63M-45.05M45.16M39.74M-35.74M38.40M46.46M-104.40M99.17M105.83M207.93M183.53M136.37M125.67M91.66M86.93M39.95M37.68M-12.51M4.06M8.44M8.16M117.17M
EBITDA -----------------------------------52.36M-83.83M87.25M45.35M152.83M
Interest Expense -----------------------------------12.32M11.36M9.63M12.28M6.71M
Pretax Income -----------------------------------183.00K-135.07M37.99M-4.16M110.46M
Tax Provision -----------------------------------1.27M-18.87M8.70M3.53M48.29M
Net Income 15.87M33.65M20.16M25.87M26.32M27.30M26.35M32.01M31.25M28.13M41.17M42.68M35.53M27.92M35.61M34.12M28.87M23.52M27.48M12.96M22.32M26.07M9.31M70.38M66.77M74.02M146.01M123.80M92.44M84.11M60.91M53.17M17.33M16.24M--1.09M-116.20M29.29M-7.70M62.17M
Diluted EPS 0.320.690.410.530.530.550.540.650.630.570.840.870.730.580.740.710.610.490.580.270.470.550.191.471.391.543.092.772.102.021.551.390.450.42--0.03-3.020.76-0.201.59

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue 759.79M669.91M887.47M953.95M1.01B1.04B1.46B1.90B1.99B2.14B2.22B2.39B3.98B5.24B3.79B2.98B2.73B
Cost of Revenue -------------3.53B2.54B2.06B1.96B
Gross Profit 204.42M184.36M249.32M270.40M297.28M316.12M469.36M619.72M644.42M696.38M743.47M791.78M1.31B1.72B1.25B919.38M774.06M
Operating Expenses -------------1.07B903.35M799.59M740.89M
Operating Income -153.61M-43.78M37.65M53.34M65.50M67.90M128.88M191.63M212.44M202.83M176.91M149.26M478.00M647.10M346.23M119.78M33.17M
EBITDA -------------784.21M499.36M71.11M101.13M
Interest Expense -------------40.40M54.14M69.90M45.59M
Pretax Income -------------606.70M284.29M-172.57M-101.06M
Tax Provision -------------162.65M73.61M-25.59M-5.36M
Net Income -122.18M-51.99M-26.27M17.14M32.93M33.22M81.89M105.84M132.56M141.74M113.99M70.67M327.39M444.05M210.68M-146.98M-95.70M
Diluted EPS -3.75-1.49-0.570.370.690.691.682.152.682.912.401.486.819.905.36-3.85-2.48

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets --562.11M535.63M517.39M604.29M680.73M880.43M1.19B1.25B1.49B1.93B2.35B-2.89B2.92B2.42B2.09B
Current Assets --------------1.09B841.68M594.91M545.38M
Cash & Equivalents 11.32M27.05M1.88M3.96M5.68M15.58M13.07M9.58M10.62M15.15M13.86M82.98M29.21M-64.52M32.94M10.65M33.97M
Inventory ------------------
Receivables --------------944.38M741.19M508.30M430.60M
Total Liabilities --380.28M375.90M335.27M386.55M424.15M532.57M737.50M691.43M853.73M1.19B1.53B-1.84B2.09B1.71B1.45B
Current Liabilities --117.89M140.05M109.53M143.09M178.29M251.02M274.79M265.27M307.27M378.11M422.96M-857.93M656.12M545.78M577.61M
Long Term Debt ---174.20M158.18M148.67M144.38M180.99M359.19M319.84M440.61M617.16M857.96M-843.50M1.30B1.06B767.05M
Total Debt --------------860.96M1.35B1.10B803.20M
Total Equity 284.13M170.84M153.46M135.66M182.11M217.74M256.58M347.86M449.38M562.53M638.99M736.74M819.68M-1.04B831.26M706.62M642.11M
Shares Outstanding --------------50.11M50.42M50.69M51.05M

Cash Flows (Annual)

Figures in USD.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow 98.73M8.09M19.31M58.38M60.17M27.68M56.31M133.91M160.52M226.99M224.86M256.83M-653.73M372.17M320.42M269.46M
Investing Cash Flow -29.25M-6.85M-1.98M1.58M-49.20M-28.23M-116.08M-258.36M-35.36M-279.34M-291.82M-538.17M--170.71M-412.49M-79.94M4.30M
Financing Cash Flow -53.81M-26.45M-15.30M-58.17M-1.02M-2.10M56.20M126.29M-77.19M37.51M136.60M211.49M--591.87M10.73M-259.45M-295.89M
Capital Expenditure -3.79M-4.17M-4.65M-5.47M-9.05M-19.13M-27.01M-21.96M-26.53M-35.21M-35.22M-37.70M--80.92M-105.39M-80.89M-35.63M
Free Cash Flow 94.94M3.92M14.66M52.91M51.12M8.54M29.30M111.95M133.99M191.79M189.64M219.12M-572.81M266.78M239.53M233.83M
Net Change in Cash --------------108.84M-29.60M-18.97M-22.13M
Share Buybacks -----0013.26M20.16M67.01M18.70M02.69M576.77M424.74M00

Ratios (Annual)

Figures in %.

Metric Dec 2009Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % 26.9%27.5%28.1%28.3%29.4%30.5%32.1%32.6%32.4%32.6%33.5%33.1%32.9%32.7%33.0%30.8%28.3%
Operating Margin % -20.2%-6.5%4.2%5.6%6.5%6.6%8.8%10.1%10.7%9.5%8.0%6.2%12.0%12.3%9.1%4.0%1.2%
Net Margin % -16.1%-7.8%-3.0%1.8%3.3%3.2%5.6%5.6%6.7%6.6%5.1%3.0%8.2%8.5%5.6%-4.9%-3.5%
ROE % -71.5%-33.9%-19.4%9.4%15.1%12.9%23.5%23.6%23.6%22.2%15.5%8.6%-42.5%25.3%-20.8%-14.9%
ROCE % --9.9%9.5%13.1%14.2%13.5%20.5%21.0%21.5%17.1%11.4%7.7%-31.9%15.3%6.4%2.2%

Shareholding Pattern

Insiders
0.97%
Institutions
115.66%
Public Float
116.80%

Top Institutional Holders

#Holder% HeldSharesValue
1 Blackrock Inc. 15.53% 6.02M $195.76M
2 Boston Partners 5.51% 2.14M $69.50M
3 Vanguard Capital Management LLC 4.32% 1.68M $54.52M
4 State Street Corporation 4.16% 1.61M $52.47M
5 Two Sigma Investments, LP 4.09% 1.59M $51.60M
6 Arrowstreet Capital, Limited Partnership 3.61% 1.40M $45.56M
7 Renaissance Technologies, LLC 3.55% 1.38M $44.73M
8 Morgan Stanley 3.46% 1.34M $43.57M
9 Allianz Asset Management GmbH 3.25% 1.26M $40.98M
10 Vanguard Portfolio Management LLC 2.90% 1.12M $36.55M

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for AMN

Yahoo Finance Wed, 08 Jul 2026

3 Reasons to Sell AMN and 1 Stock to Buy Instead

AMN Healthcare Services has been on fire lately. In the past six months alone, the company’s stock price has rocketed 113%, setting a new 52-week high of $33.29 per share. This was partly due to its solid quarterly results, and the performa…

Yahoo Finance ue, 07 Jul 2026

AMN Healthcare to Hold Second Quarter 2026 Earnings Conference Call on Thursday, August 6, 2026

AMN Healthcare Services, Inc. (NYSE: AMN), has scheduled a conference call to discuss its second quarter 2026 financial results and third quarter 2026 outlook on Thursday, August 6, 2026, at 5:00 p.m. Eastern Time. On the same day, the Comp…

Yahoo Finance ue, 07 Jul 2026

Here's Why You Should Retain AMN Stock in Your Portfolio for Now

AMN Healthcare's MSP momentum, labor disruption demand and AI-driven staffing tools support growth. But pricing pressure and industry shifts remain key risks.

Yahoo Finance Mon, 06 Jul 2026

3 Unpopular Stocks We Keep Off Our Radar

Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps delivering the hard truth.…

Yahoo Finance hu, 02 Jul 2026

Dassault Aviation: Total number of shares and voting rights - 30 06 26

DASSAULT AVIATION French corporation (société anonyme) with a share capital of 62,170,196.80 euros Headquarters: 78, quai Marcel Dassault 92210 SAINT-CLOUD 712 042 456 RCS Nanterre Information concerning the total number of voting rights an…

Yahoo Finance hu, 02 Jul 2026

1 Healthcare Stock with Impressive Fundamentals and 2 We Turn Down

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 16.3% over the past six months, topping the S&P 50…

AMN — Frequently Asked Questions

What is the current share price of AMN Healthcare Services, Inc. (AMN)?

As of 2026-07-15 16:51 PDT, AMN Healthcare Services, Inc. (AMN) trades at $32.35 on NYSE. Its 52-week range is $15.10 to $35.77.

What is the market capitalisation of AMN?

AMN Healthcare Services, Inc. (AMN) has a market capitalisation of $1.25B on NYSE.

What is the P/E ratio of AMN?

AMN trades at a trailing price-to-earnings (P/E) ratio of -39.45. The industry average P/E is 25.88. Its price-to-book (P/B) ratio is 1.76.

What is the return on equity (ROE) of AMN?

AMN has a return on equity (ROE) of -4.54%. Its return on capital employed (ROCE) is -3.66%.

Is AMN a good stock to buy?

This page provides a data-driven analysis of AMN Healthcare Services, Inc. (AMN), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space